Postoperative pain following laparoscopic gastrectomy
Conditions
Interventions
PCA Continuous Infusion Group:Tileridine PCA Continuous Infusion
Q8h Intermittent Intravenous Injection Group:Q8h Intermittent Intravenous Injection of Tileridine
Sponsors
Weifang People's Hospital
Eligibility
Sex/Gender
All
Age
45 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 45 to 70 years ; 2. Patients scheduled for laparoscopic gastrectomy under general anesthesia. 3. Patients undergoing endotracheal intubation under general anesthesia, with an ASA (American Society of Anesthesiologists) physical status classification of I to III. 4. Body Mass Index (BMI) between 18 kg/m^2 and 30 kg/m^2. 5. Participants fully understand the purpose, content, procedures, and risks of the trial, and voluntarily participate in the clinical trial by signing the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with severe cardiovascular, cerebrovascular, hepatic, or renal diseases. 2. Patients with a history of mental disorders and long-term use of psychotropic medications, who have cognitive impairments. 3. Patients who are allergic to opioids or their components, or have contraindications to their use. 4. Participants who have taken part in a drug clinical trial within the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area under the curve of pain score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of adverse reactions;Sedation level;Quality of recovery score at 48 hours postoperatively;Number of rescue doses;Time to first flatus after surgery;Patient satisfaction score for analgesia; | — |
Countries
China
Contacts
Public ContactJun Hu
Weifang People's Hospital
Outcome results
None listed